Resistance patterns of anthracycline analogues in acute myeloid leukemia using the MTT assay
Kaspers G et al. (eds). Harwood Academic, London
Sargent JM, Elgie AW, Taylor CG, Faulkner Pulsford J. Resistance patterns of anthracycline analogues in acute myeloid leukemia using the MTT assay. In: Kaspers G et al. (eds). Drug resistance in leukemia and lymphoma: the clinical value of laboratory studies, 1993, Harwood Academic, London, 285-291.
In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia
Klumper E, Ossenkoppele GJ, Pieters R, Huismans DR, Loonen AH, Rottier A, Westra G, Veerman AJP. In vitro resistance to cytosine arabinoside, not to daunorubicin, is associated with the risk of relapse in de novo acute myeloid leukaemia. Br J Haematol, 1996, 93, 903-910.
Schilsky RL et al. (eds), Marcel Dekker Inc, New York
Peters GJ, Jansen G. Resistance to antimetabolites. In: Schilsky RL et al. (eds), Principles of antineoplastic drug development and pharmacology, 1996, Marcel Dekker Inc, New York, 543-585.
Phase I and clinical evaluation of aphidicolin glycinate
Sessa C, Zucchetti M, Davoli E, Califano R, Cavalli F, Fristaci S, Gumbrell L, Sulkes A, Winograd B, D'lncalci M. Phase I and clinical evaluation of aphidicolin glycinate. J Natl Cancer Inst, 1991, 83, 1160-1164.
Effect of DMA polymerase inhibitors on repair of γ ray-induced DNA damage in proliferating (intact versus permeable) human fibroblasts: Evidence for differences in the modes of action of aphidicolin and 1-β-D-arabinofuranosylcytosine
Mirzayans R, Enns L, Cubitt S, Karimian K, Radatus B, Paterson MC. Effect of DMA polymerase inhibitors on repair of γ ray-induced DNA damage in proliferating (intact versus permeable) human fibroblasts: evidence for differences in the modes of action of aphidicolin and 1-β-D-arabinofuranosylcytosine. 1994, Biochim Biophys Acta 1227, 92-100.
